1 6221 138 THE LANDSCAPE OF HISTONE MODIFICATIONS IN A HIGH-FAT DIET-INDUCED OBESE (DIO) MOUSE MODEL. TYPE 2 DIABETES (T2D) IS A MAJOR CHRONIC HEALTHCARE CONCERN WORLDWIDE. EMERGING EVIDENCE SUGGESTS THAT A HISTONE-MODIFICATION-MEDIATED EPIGENETIC MECHANISM UNDERLIES T2D. NEVERTHELESS, THE DYNAMICS OF HISTONE MARKS IN T2D HAVE NOT YET BEEN CAREFULLY ANALYZED. USING A MASS SPECTROMETRY-BASED LABEL-FREE AND CHEMICAL STABLE ISOTOPE LABELING QUANTITATIVE PROTEOMIC APPROACH, WE SYSTEMATICALLY PROFILED LIVER HISTONE POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN A PREDIABETIC HIGH-FAT DIET-INDUCED OBESE (DIO) MOUSE MODEL. WE IDENTIFIED 170 HISTONE MARKS, 30 OF WHICH WERE PREVIOUSLY UNKNOWN. INTERESTINGLY, ABOUT 30% OF THE HISTONE MARKS IDENTIFIED IN DIO MOUSE LIVER BELONGED TO A SET OF RECENTLY REPORTED LYSINE ACYLATION MODIFICATIONS, INCLUDING PROPIONYLATION, BUTYRYLATION, MALONYLATION, AND SUCCINYLATION, SUGGESTING POSSIBLE ROLES OF THESE NEWLY IDENTIFIED HISTONE ACYLATIONS IN DIABETES AND OBESITY. THESE HISTONE MARKS WERE DETECTED WITHOUT PRIOR AFFINITY ENRICHMENT WITH AN ANTIBODY, DEMONSTRATING THAT THE HISTONE ACYLATION MARKS ARE PRESENT AT REASONABLY HIGH STOICHIOMETRY. FIFTEEN HISTONE MARKS DIFFERED IN ABUNDANCE IN DIO MOUSE LIVER COMPARED WITH LIVER FROM CHOW-FED MICE IN LABEL-FREE QUANTIFICATION, AND SIX HISTONE MARKS IN STABLE ISOTOPE LABELING QUANTIFICATION. ANALYSIS OF HEPATIC HISTONE MODIFICATIONS FROM METFORMIN-TREATED DIO MICE REVEALED THAT METFORMIN, A DRUG WIDELY USED FOR T2D, COULD REVERSE DIO-STIMULATED HISTONE H3K36ME2 IN PREDIABETES, SUGGESTING THAT THIS MARK IS LIKELY ASSOCIATED WITH T2D DEVELOPMENT. OUR STUDY THUS OFFERS A COMPREHENSIVE LANDSCAPE OF HISTONE MARKS IN A PREDIABETIC MOUSE MODEL, PROVIDES A RESOURCE FOR STUDYING EPIGENETIC FUNCTIONS OF HISTONE MODIFICATIONS IN OBESITY AND T2D, AND SUGGEST A NEW EPIGENETIC MECHANISM FOR THE PHYSIOLOGICAL FUNCTION OF METFORMIN. 2017 2 4185 31 METABOLIC ADAPTIONS/REPROGRAMMING IN ISLET BETA-CELLS IN RESPONSE TO PHYSIOLOGICAL STIMULATORS-WHAT ARE THE CONSEQUENCES. IRREVERSIBLE PANCREATIC BETA-CELL DAMAGE MAY BE A RESULT OF CHRONIC EXPOSURE TO SUPRAPHYSIOLOGICAL GLUCOSE OR LIPID CONCENTRATIONS OR CHRONIC EXPOSURE TO THERAPEUTIC ANTI-DIABETIC DRUGS. THE BETA-CELLS ARE ABLE TO RESPOND TO BLOOD GLUCOSE IN A NARROW CONCENTRATION RANGE AND RELEASE INSULIN IN RESPONSE, FOLLOWING ACTIVATION OF METABOLIC PATHWAYS SUCH AS GLYCOLYSIS AND THE TCA CYCLE. THE BETA-CELL CANNOT PROTECT ITSELF FROM GLUCOSE TOXICITY BY BLOCKING GLUCOSE UPTAKE, BUT INDEED RELIES ON ALTERNATIVE METABOLIC PROTECTION MECHANISMS TO AVOID DYSFUNCTION AND DEATH. ALTERATION OF NORMAL METABOLIC PATHWAY FUNCTION OCCURS AS A COUNTER REGULATORY RESPONSE TO HIGH NUTRIENT, INFLAMMATORY FACTOR, HORMONE OR THERAPEUTIC DRUG CONCENTRATIONS. METABOLIC REPROGRAMMING IS A TERM WIDELY USED TO DESCRIBE A CHANGE IN REGULATION OF VARIOUS METABOLIC ENZYMES AND TRANSPORTERS, USUALLY ASSOCIATED WITH CELL GROWTH AND PROLIFERATION AND MAY INVOLVE RESHAPING EPIGENETIC RESPONSES, IN PARTICULAR THE ACETYLATION AND METHYLATION OF HISTONE PROTEINS AND DNA. OTHER METABOLIC MODIFICATIONS SUCH AS MALONYLATION, SUCCINYLATION, HYDROXYBUTYRYLATION, ADP-RIBOSYLATION, AND LACTYLATION, MAY IMPACT REGULATORY PROCESSES, MANY OF WHICH NEED TO BE INVESTIGATED IN DETAIL TO CONTRIBUTE TO CURRENT ADVANCES IN METABOLISM. BY DESCRIBING MULTIPLE MECHANISMS OF METABOLIC ADAPTION THAT ARE AVAILABLE TO THE BETA-CELL ACROSS ITS LIFESPAN, WE HOPE TO IDENTIFY SITES FOR METABOLIC REPROGRAMMING MECHANISMS, MOST OF WHICH ARE INCOMPLETELY DESCRIBED OR UNDERSTOOD. MANY OF THESE MECHANISMS ARE RELATED TO PROMINENT ANTIOXIDANT RESPONSES. HERE, WE HAVE ATTEMPTED TO DESCRIBE THE KEY BETA-CELL METABOLIC ADAPTIONS AND CHANGES WHICH ARE REQUIRED FOR SURVIVAL AND FUNCTION IN VARIOUS PHYSIOLOGICAL, PATHOLOGICAL AND PHARMACOLOGICAL CONDITIONS. 2022 3 46 29 A CONCEPTUAL FRAMEWORK FOR THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE. IN THE LAST DECADES, THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD) HAVE EMERGED AS A VIGOROUS FIELD COMBINING EXPERIMENTAL, CLINICAL, EPIDEMIOLOGICAL AND PUBLIC HEALTH RESEARCH. ITS GOAL IS TO UNDERSTAND HOW EVENTS IN EARLY LIFE SHAPE LATER MORBIDITY RISK, ESPECIALLY OF NON-COMMUNICABLE CHRONIC DISEASES. AS THESE DISEASES BECOME THE MAJOR CAUSE OF MORBIDITY AND MORTALITY WORLDWIDE, RESEARCH ARISING FROM DOHAD IS LIKELY TO GAIN SIGNIFICANCE TO PUBLIC HEALTH AND ECONOMIC DEVELOPMENT. BUT ACTION MAY BE HINDERED BY THE LACK OF A FIRM MECHANISTIC EXPLANATION AND OF A CONCEPTUAL BASIS, ESPECIALLY REGARDING THE EVOLUTIONARY SIGNIFICANCE OF THE DOHAD PHENOMENON. IN THIS ARTICLE, WE PROVIDE A SUCCINCT HISTORICAL REVIEW OF THE RESEARCH INTO THE RELATIONSHIP BETWEEN DEVELOPMENT AND LATER DISEASE, CONSIDER THE EVOLUTIONARY AND DEVELOPMENTAL SIGNIFICANCE AND DISCUSS THE UNDERLYING MECHANISMS OF THE DOHAD PHENOMENON. DOHAD SHOULD BE VIEWED AS A PART OF A BROADER BIOLOGICAL MECHANISM OF PLASTICITY BY WHICH ORGANISMS, IN RESPONSE TO CUES SUCH AS NUTRITION OR HORMONES, ADAPT THEIR PHENOTYPE TO ENVIRONMENT. THESE RESPONSES MAY BE DIVIDED INTO THOSE FOR IMMEDIATE BENEFIT AND THOSE AIMED AT PREDICTION OF A FUTURE ENVIRONMENT: DISEASE OCCURS IN THE MISMATCH BETWEEN PREDICTED AND REALIZED FUTURE. THE LIKELY MECHANISMS THAT ENABLE PLASTICITY INVOLVE EPIGENETIC PROCESSES, AFFECTING THE EXPRESSION OF GENES ASSOCIATED WITH REGULATORY PATHWAYS. THERE IS NOW EVIDENCE THAT EPIGENETIC MARKS MAY BE INHERITED AND SO CONTRIBUTE TO NON-GENOMIC HERITABLE DISEASE RISK. WE END BY DISCUSSING THE GLOBAL SIGNIFICANCE OF THE DOHAD PHENOMENON AND ITS POTENTIAL APPLICATIONS FOR PUBLIC HEALTH PURPOSES. 2010 4 4340 19 MIGRATION OF STEM-LIKE CD8 T CELLS BETWEEN TISSUE MICROENVIRONMENTS UNDERPINS SUCCESSFUL ANTI-TUMOUR IMMUNE RESPONSES. THE CLINICAL SUCCESS OF IMMUNE CHECKPOINT BLOCKADE IN SOME PATIENTS HAS TRANSFORMED TREATMENT APPROACHES IN CANCER AND OFFERS THE HOPE OF DURABLE CURATIVE RESPONSES. BUILDING FROM STUDIES OF CHRONIC INFECTION, THE COMPOSITION OF TUMOUR INFILTRATING LYMPHOCYTES AND IN PARTICULAR, THE SPECTRUM OF EXHAUSTED CD8 T CELLS HAS NOW BEEN CHARACTERIZED IN DETAIL, PROFILING THE PHENOTYPE, FUNCTION, TRANSCRIPTIONAL REGULATION AND EVEN THE EPIGENETIC CHANGES. HOWEVER, WHAT REMAINS LESS CLEAR IS HOW INTRATUMOURAL IMMUNE CELLS INTERFACE WITH POPULATIONS IN THE PERIPHERY, BOTH IN TERMS OF SUSTAINING THE RESPONSE IN CANCER, BUT ALSO IN ESTABLISHING SYSTEMIC MEMORY RESPONSES THAT CAN PROVIDE LONG-TERM PROTECTION. HERE WE WILL SUCCINCTLY REVIEW THE CURRENT UNDERSTANDING OF THE ANTI-TUMOUR RESPONSE, CONSIDER THE TISSUE MICROENVIRONMENTS THAT SUPPORT KEY CELLULAR SUBSETS AND THE EXTENT TO WHICH CELLULAR MIGRATION BETWEEN THESE SITES IMPACTS THE RESPONSE. 2023 5 6622 30 UNDERSTANDING HAT1: A COMPREHENSIVE REVIEW OF NONCANONICAL ROLES AND CONNECTION WITH DISEASE. HISTONE ACETYLATION PLAYS A VITAL ROLE IN ORGANIZING CHROMATIN, REGULATING GENE EXPRESSION AND CONTROLLING THE CELL CYCLE. THE FIRST HISTONE ACETYLTRANSFERASE TO BE IDENTIFIED WAS HISTONE ACETYLTRANSFERASE 1 (HAT1), BUT IT REMAINS ONE OF THE LEAST UNDERSTOOD ACETYLTRANSFERASES. HAT1 CATALYZES THE ACETYLATION OF NEWLY SYNTHESIZED H4 AND, TO A LESSER EXTENT, H2A IN THE CYTOPLASM. HOWEVER, 20 MIN AFTER ASSEMBLY, HISTONES LOSE ACETYLATION MARKS. MOREOVER, NEW NONCANONICAL FUNCTIONS HAVE BEEN DESCRIBED FOR HAT1, REVEALING ITS COMPLEXITY AND COMPLICATING THE UNDERSTANDING OF ITS FUNCTIONS. RECENTLY DISCOVERED ROLES INCLUDE FACILITATING THE TRANSLOCATION OF THE H3H4 DIMER INTO THE NUCLEUS, INCREASING THE STABILITY OF THE DNA REPLICATION FORK, REPLICATION-COUPLED CHROMATIN ASSEMBLY, COORDINATION OF HISTONE PRODUCTION, DNA DAMAGE REPAIR, TELOMERIC SILENCING, EPIGENETIC REGULATION OF NUCLEAR LAMINA-ASSOCIATED HETEROCHROMATIN, REGULATION OF THE NF-KAPPAB RESPONSE, SUCCINYL TRANSFERASE ACTIVITY AND MITOCHONDRIAL PROTEIN ACETYLATION. IN ADDITION, THE FUNCTIONS AND EXPRESSION LEVELS OF HAT1 HAVE BEEN LINKED TO MANY DISEASES, SUCH AS MANY TYPES OF CANCER, VIRAL INFECTIONS (HEPATITIS B VIRUS, HUMAN IMMUNODEFICIENCY VIRUS AND VIPERIN SYNTHESIS) AND INFLAMMATORY DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROSCLEROSIS AND ISCHEMIC STROKE). THE COLLECTIVE DATA REVEAL THAT HAT1 IS A PROMISING THERAPEUTIC TARGET, AND NOVEL THERAPEUTIC APPROACHES, SUCH AS RNA INTERFERENCE AND THE USE OF APTAMERS, BISUBSTRATE INHIBITORS AND SMALL-MOLECULE INHIBITORS, ARE BEING EVALUATED AT THE PRECLINICAL LEVEL. 2023 6 1748 24 EARLY LIFE EVENTS AND THEIR CONSEQUENCES FOR LATER DISEASE: A LIFE HISTORY AND EVOLUTIONARY PERSPECTIVE. BIOMEDICAL SCIENCE HAS LITTLE CONSIDERED THE RELEVANCE OF LIFE HISTORY THEORY AND EVOLUTIONARY AND ECOLOGICAL DEVELOPMENTAL BIOLOGY TO CLINICAL MEDICINE. HOWEVER, THE OBSERVATIONS THAT EARLY LIFE INFLUENCES CAN ALTER LATER DISEASE RISK--THE "DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE" (DOHAD) PARADIGM--HAVE LED TO A RECOGNITION THAT THESE PERSPECTIVES CAN INFORM OUR UNDERSTANDING OF HUMAN BIOLOGY. WE PROPOSE THAT THE DOHAD PHENOMENON CAN BE CONSIDERED AS A SUBSET OF THE BROADER PROCESSES OF DEVELOPMENTAL PLASTICITY BY WHICH ORGANISMS ADAPT TO THEIR ENVIRONMENT DURING THEIR LIFE COURSE. SUCH ADAPTIVE PROCESSES ALLOW GENOTYPIC VARIATION TO BE PRESERVED THROUGH TRANSIENT ENVIRONMENTAL CHANGES. CUES FOR PLASTICITY OPERATE PARTICULARLY DURING EARLY DEVELOPMENT; THEY MAY AFFECT A SINGLE ORGAN OR SYSTEM, BUT GENERALLY THEY INDUCE INTEGRATED ADJUSTMENTS IN THE MATURE PHENOTYPE, A PROCESS UNDERPINNED BY EPIGENETIC MECHANISMS AND INFLUENCED BY PREDICTION OF THE MATURE ENVIRONMENT. IN MAMMALS, AN ADVERSE INTRAUTERINE ENVIRONMENT RESULTS IN AN INTEGRATED SUITE OF RESPONSES, SUGGESTING THE INVOLVEMENT OF A FEW KEY REGULATORY GENES, THAT RESETS THE DEVELOPMENTAL TRAJECTORY IN EXPECTATION OF POOR POSTNATAL CONDITIONS. MISMATCH BETWEEN THE ANTICIPATED AND THE ACTUAL MATURE ENVIRONMENT EXPOSES THE ORGANISM TO RISK OF ADVERSE CONSEQUENCES-THE GREATER THE MISMATCH, THE GREATER THE RISK. FOR HUMANS, PREDICTION IS INACCURATE FOR MANY INDIVIDUALS BECAUSE OF CHANGES IN THE POSTNATAL ENVIRONMENT TOWARD ENERGY-DENSE NUTRITION AND LOW ENERGY EXPENDITURE, CONTRIBUTING TO THE EPIDEMIC OF CHRONIC NONCOMMUNICABLE DISEASE. THIS VIEW OF HUMAN DISEASE FROM THE PERSPECTIVES OF LIFE HISTORY BIOLOGY AND EVOLUTIONARY THEORY OFFERS NEW APPROACHES TO PREVENTION, DIAGNOSIS AND INTERVENTION. 2007 7 2586 20 EPIGENETICS OF PAIN MEDIATORS. PURPOSE OF REVIEW: THE FIELD OF EPIGENETICS CONTINUES ITS INFLUENTIAL RISE AS A MEANS TO BETTER UNDERSTAND AN ORGANISM'S UNIQUE DEVELOPMENTAL IDENTITY OVER A LIFESPAN. WHEREAS A GENOME IS CONSTANT AND UNCHANGING, AN EPIGENOME IS DYNAMIC AND ALTERABLE. EPIGENETIC CHANGES ARE IN RESPONSE TO INNUMERABLE INTERNAL AND EXTERNAL INFLUENCES INCLUDING ENVIRONMENTAL CHANGES SUCH AS DIET, EXERCISE, DISEASE, TOXINS, AND STRESS. EPIGENETICS IS OF PARTICULAR INTEREST IN THE MEDICAL RESEARCH COMMUNITY BOTH FOR THE POTENTIAL TO CAUSE DISEASE AND AS A TARGET FOR THERAPEUTIC INTERVENTIONS. THIS ARTICLE PROVIDES A SUCCINCT EXPLANATION OF THE POTENTIAL FOR EPIGENETICS TO INFLUENCE THE UNDERSTANDING OF PAIN AS WELL AS A REVIEW OF RELEVANT RESEARCH ON THE TOPIC. RECENT FINDINGS: STUDIES ON EPIGENETICS AND PAIN REMAIN LARGELY PRECLINICAL AND INVESTIGATE THE THEORETICAL ABILITY OF EPIGENETICS TO ALTER THE NOCICEPTIVE PATHWAYS BOTH IN THE PERIPHERY AND CENTRALLY. SIGNIFICANT EVIDENCE NOW EXISTS FOR THE ABILITY OF EPIGENETICS TO MODIFY BROADLY CATEGORIZED PAIN TYPES, INCLUDING INFLAMMATORY, NEUROPATHIC, VISCERAL, AND CANCER RELATED. SUMMARY: BOTH PATIENTS AND PROVIDERS RECOGNIZE THAT NOVEL MEDICATIONS FOR THE TREATMENT OF BOTH ACUTE AND CHRONIC PAIN CONDITIONS ARE SORELY NEEDED. THE UNDERSTANDING OF EPIGENETICS AND ITS INFLUENCE ON NOCICEPTION REMAINS IN RELATIVE INFANCY BUT EARLY EVIDENCE IS STRONG FOR POTENTIAL THERAPEUTIC BENEFITS TO TREAT THESE CONDITIONS. 2018 8 4774 31 NUCLEIC ACID APTAMERS TARGETING EPIGENETIC REGULATORS: AN INNOVATIVE THERAPEUTIC OPTION. EPIGENETIC MECHANISMS INCLUDE DNA METHYLATION, POSTTRANSLATIONAL MODIFICATIONS OF HISTONES, CHROMATIN REMODELING FACTORS, AND POST TRANSCRIPTIONAL GENE REGULATION BY NONCODING RNAS. ALL TOGETHER, THESE PROCESSES REGULATE GENE EXPRESSION BY CHANGING CHROMATIN ORGANIZATION AND DNA ACCESSIBILITY. TARGETING ENZYMATIC REGULATORS RESPONSIBLE FOR DNA AND CHROMATIN MODIFICATIONS HOLD PROMISE FOR MODULATING THE TRANSCRIPTIONAL REGULATION OF GENES THAT ARE INVOLVED IN CANCER, AS WELL AS IN CHRONIC NONCOMMUNICABLE METABOLIC DISEASES LIKE OBESITY, DIABETES, AND CARDIOVASCULAR DISEASES. INCREASINGLY STUDIES ARE EMERGING, LEADING TO THE IDENTIFICATION OF SPECIFIC AND EFFECTIVE MOLECULES TARGETING EPIGENETIC PATHWAYS INVOLVED IN DISEASE ONSET. IN THIS REGARD, RNA INTERFERENCE, WHICH USES SMALL RNAS TO REDUCE GENE EXPRESSION AND NUCLEIC ACID APTAMERS ARE ARISING AS VERY PROMISING CANDIDATES IN THERAPEUTIC APPROACH. COMMON TO ALL THESE STRATEGIES IS THE IMPERATIVE CHALLENGE OF SPECIFICITY. IN THIS REGARD, NUCLEIC ACID APTAMERS HAVE EMERGED AS AN ATTRACTIVE CLASS OF CARRIER MOLECULES DUE TO THEIR ABILITY TO BIND WITH HIGH AFFINITY TO SPECIFIC LIGANDS, THEIR HIGH CHEMICAL FLEXIBILITY AS WELL AS TISSUE PENETRATION CAPABILITY. IN THIS REVIEW, WE WILL FOCUS ON THE RECENT PROGRESS IN THE FIELD OF APTAMERS USED AS TARGETING MOIETIES ABLE TO RECOGNIZE AND REVERT EPIGENETICS MARKS INVOLVED IN DISEASES ONSET. 2018 9 5570 33 ROLE OF MELATONIN IN METABOLIC REGULATION. ALTHOUGH THE HUMAN GENOME HAS REMAINED UNCHANGED OVER THE LAST 10,000 YEARS, OUR LIFESTYLE HAS BECOME PROGRESSIVELY MORE DIVERGENT FROM THOSE OF OUR ANCIENT ANCESTORS. THIS MALADAPTIVE CHANGE BECAME APPARENT WITH THE INDUSTRIAL REVOLUTION AND HAS BEEN ACCELERATING IN RECENT DECADES. SOCIALLY, WE ARE PEOPLE OF THE 21ST CENTURY, BUT GENETICALLY WE REMAIN SIMILAR TO OUR EARLY ANCESTORS. IN CONJUNCTION WITH THIS DISCORDANCE BETWEEN OUR ANCIENT, GENETICALLY-DETERMINED BIOLOGY AND THE NUTRITIONAL, CULTURAL AND ACTIVITY PATTERNS IN CONTEMPORARY WESTERN POPULATIONS, MANY DISEASES HAVE EMERGED. ONLY A CENTURY AGO INFECTIOUS DISEASE WAS A MAJOR CAUSE OF MORTALITY, WHEREAS TODAY NON-INFECTIOUS CHRONIC DISEASES ARE THE GREATEST CAUSE OF DEATH IN THE WORLD. EPIDEMICS OF METABOLIC DISEASES (E.G., CARDIOVASCULAR DISEASES, TYPE 2 DIABETES, OBESITY, METABOLIC SYNDROME AND CERTAIN CANCERS) HAVE BECOME MAJOR CONTRIBUTORS TO THE BURDEN OF POOR HEALTH AND THEY ARE PRESENTLY EMERGING OR ACCELERATING, IN MOST DEVELOPING COUNTRIES. ONE MAJOR LIFESTYLE CONSEQUENCE IS LIGHT AT NIGHT AND SUBSEQUENT DISRUPTED CIRCADIAN RHYTHMS COMMONLY REFERRED TO AS CIRCADIAN DISRUPTION OR CHRONODISRUPTION. MOUNTING EVIDENCE REVEALS THAT PARTICULARLY MELATONIN RHYTHMICITY HAS CRUCIAL ROLES IN A VARIETY OF METABOLIC FUNCTIONS AS AN ANTI-OXIDANT, ANTI-INFLAMMATORY CHRONOBIOTIC AND POSSIBLY AS AN EPIGENETIC REGULATOR. THIS PAPER PROVIDES A BRIEF OUTLINE ABOUT METABOLIC DYSREGULATION IN CONJUNCTION WITH A DISRUPTED MELATONIN RHYTHM. 2009 10 6732 18 WESTERN DIET AND THE IMMUNE SYSTEM: AN INFLAMMATORY CONNECTION. THE CONSUMPTION OF WESTERN-TYPE CALORICALLY RICH DIETS COMBINED WITH CHRONIC OVERNUTRITION AND A SEDENTARY LIFESTYLE IN WESTERN SOCIETIES EVOKES A STATE OF CHRONIC METABOLIC INFLAMMATION, TERMED METAFLAMMATION. METAFLAMMATION CONTRIBUTES TO THE DEVELOPMENT OF MANY PREVALENT NON-COMMUNICABLE DISEASES (NCDS), AND THESE LIFESTYLE-ASSOCIATED PATHOLOGIES REPRESENT A RISING PUBLIC HEALTH PROBLEM WITH GLOBAL EPIDEMIC DIMENSIONS. A BETTER UNDERSTANDING OF HOW MODERN LIFESTYLE AND WESTERN DIET (WD) ACTIVATE IMMUNE CELLS IS ESSENTIAL FOR THE DEVELOPMENT OF EFFICIENT PREVENTIVE AND THERAPEUTIC STRATEGIES FOR COMMON NCDS. HERE, WE REVIEW THE CURRENT MECHANISTIC UNDERSTANDING OF HOW THE WESTERN LIFESTYLE CAN INDUCE METAFLAMMATION, AND WE DISCUSS HOW THIS KNOWLEDGE CAN BE TRANSLATED TO PROTECT THE PUBLIC FROM THE HEALTH BURDEN ASSOCIATED WITH THEIR SELECTED LIFESTYLE. 2019 11 3818 17 INTRINSIC AND ENVIRONMENTAL BASIS OF AGING: A NARRATIVE REVIEW. LONGEVITY HAS BEEN A TOPIC OF INTEREST SINCE THE BEGINNINGS OF HUMANITY, YET ITS AETIOLOGY AND PRECISE MECHANISMS REMAIN TO BE ELUCIDATED. AGING IS CURRENTLY VIEWED AS A PHYSIOLOGICAL PHENOMENON CHARACTERIZED BY THE GRADUAL DEGENERATION OF ORGANIC PHYSIOLOGY AND MORPHOLOGY DUE TO THE PASSAGE OF TIME WHERE BOTH EXTERNAL AND INTERNAL STIMULI INTERVENE. THE INFLUENCE OF INTRINSIC FACTORS, SUCH AS PROGRESSIVE TELOMERE SHORTENING, GENOME INSTABILITY DUE TO MUTATION BUILDUP, THE DIRECT OR INDIRECT ACTIONS OF AGE-RELATED GENES, AND MARKED CHANGES IN EPIGENETIC, METABOLIC, AND MITOCHONDRIAL PATTERNS CONSTITUTE A BIG PART OF ITS UNDERLYING ENDOGENOUS MECHANISMS. ON THE OTHER HAND, SEVERAL PSYCHOSOCIAL AND DEMOGRAPHIC FACTORS, SUCH AS DIET, PHYSICAL ACTIVITY, SMOKING, AND DRINKING HABITS, MAY HAVE AN EVEN MORE SIGNIFICANT IMPACT ON SHAPING THE AGING PROCESS. CONSEQUENTIALLY, IMPLEMENTING DIETARY AND EXERCISE PATTERNS HAS BEEN PROPOSED AS THE MOST VIABLE ALTERNATIVE STRATEGY FOR ATTENUATING THE MOST TYPICAL DEGENERATIVE AGING CHANGES, THUS INCREASING THE LIKELIHOOD OF PROLONGING LIFESPAN AND ACHIEVING SUCCESSFUL AGING. 2023 12 3427 20 HUMAN VARIATION IN RESPONSE TO FOOD AND NUTRIENTS. THE APPLICATION OF SCIENCE TO HUMAN NUTRITION OVER THE CENTURIES HAS SERVED SOCIETIES WELL. ONE EXAMPLE IS THE IDENTIFICATION OF KEY NUTRIENTS TO OVERCOME NUTRITIONAL DEFICIENCIES, WHICH HAS ENHANCED LIFE EXPECTANCY. ENHANCED LIFE EXPECTANCY, HOWEVER, IS ASSOCIATED WITH AN INCREASED PREVALENCE OF CHRONIC DISORDERS RELATED TO FOOD AND NUTRITION. FINDINGS OF STUDIES INDICATING THAT INDIVIDUAL RESPONSES TO NUTRIENTS DIFFER SUBSTANTIALLY BETWEEN INDIVIDUALS MAKE IT NECESSARY TO RE-EXAMINE THE RELATIONSHIP BETWEEN NUTRITION AND HUMAN HEALTH. THE EMERGENCE OF NEW GENOMIC-BASED TECHNOLOGIES ILLUSTRATES THE COMPLEXITY AND SCALE OF THE INTERACTIONS BETWEEN NUTRITION AND GENETIC FACTORS. EPIGENETIC MODIFICATIONS RESULTING FROM INTERACTIONS OF THE GENETIC PROFILE, AGING, AND LIFESTYLE CAN INFLUENCE THE TIME COURSE OF CHRONIC DISORDERS AND CONTRIBUTE TO HUMAN VARIABILITY IN RESPONSE TO NUTRITIONAL INTERVENTIONS. DEVELOPING A BETTER UNDERSTANDING OF HUMAN VARIABILITY AS IT APPLIES TO HUMAN NUTRITION WILL INVOLVE EMBRACING THE APPROACHES AND PRINCIPLES OF COMPLEX SCIENCE. 2020 13 1369 28 DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD). OBJECTIVE: TO PRESENT A NEW BRANCH OF SCIENTIFIC KNOWLEDGE, KNOWN AS THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD), COVERING ITS CONCEPTS, STUDY METHODS AND ETHICAL CONSIDERATIONS IN ADDITION TO THE PROSPECTS FOR THIS AREA OF KNOWLEDGE. SOURCES: A NON-SYSTEMATIC REVIEW OF THE BIOMEDICAL LITERATURE INTENDED TO IDENTIFY HISTORICAL AND CURRENT REFERENCES RELATED TO THE SUBJECT UNDER DISCUSSION. SUMMARY OF THE FINDINGS: RECENT STUDIES DEMONSTRATE ASSOCIATIONS BETWEEN AGGRESSIONS SUFFERED DURING THE INITIAL PHASES OF SOMATIC DEVELOPMENT AND AMPLIFIED RISK OF CHRONIC DISEASES THROUGHOUT LIFE, SUCH AS OBESITY, DIABETES AND CARDIOVASCULAR DISEASES. A VARIETY OF MODELS HAVE BEEN PROPOSED IN ATTEMPTS TO BETTER EXPLAIN THESE ASSOCIATIONS, SUCH AS THE THRIFTY PHENOTYPE, PROGRAMMING AND PREDICTIVE ADAPTIVE RESPONSE THEORIES AND THE CONCEPT OF MATCH OR MISMATCH. SOME OF THE MECHANISMS POSSIBLY INVOLVED IN THESE PROCESSES ARE: EFFECTS OF THE ENVIRONMENT ON GENE EXPRESSION, THROUGH EPIGENETIC MECHANISMS; EFFECTS OF HORMONAL SIGNALS TRANSMITTED TO THE FETUS VIA THE PLACENTA OR THE NEWBORN VIA LACTATION. CONCLUSIONS: DOHAD DRAWS TOGETHER INFORMATION ORIGINATING FROM MANY DIFFERENT AREAS OF KNOWLEDGE, PROPOSING NEW INVESTIGATIVE METHODOLOGIES TO ELUCIDATE THE INFLUENCE OF ADVERSE EVENTS THAT OCCUR DURING EARLY PHASES OF HUMAN DEVELOPMENT ON THE PATTERN OF HEALTH AND DISEASE THROUGHOUT LIFE. THIS NEW SCIENTIFIC FIELD PROPOSES NEW MODELS OF CAUSALITY AND OF THE MECHANISMS INVOLVED IN THE EMERGENCE AND DEVELOPMENT OF CHRONIC DISEASES. THE RESULTS OF THESE INVESTIGATIONS MAY RESULT IN A SIGNIFICANT IMPACT ON THE PREVENTION OF CHRONIC DISEASES, AND ALSO ON HEALTH PROMOTION IN DIFFERENT PHASES OF LIFE. 2007 14 6792 22 [DOHAD AND EPIGENETIC INFORMATION: SOCIETAL CHALLENGES]. THE CONCEPT OF THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD) ALTERS OUR UNDERSTANDING OF WHAT CONSTITUTES "HEALTH" OR "DISEASE" INTENDED AS CHRONIC, NON-COMMUNICABLE DISEASES, WHICH DEVELOP OVER THE LIFE COURSE IN HIGH INCOME AND EMERGING COUNTRIES. IT IMPLIES A CHANGE IN PARADIGM FORMING A BASIS FOR PREVENTION POLICIES ACROSS THE GLOBE. IT ALSO IMPACTS PSYCHOLOGICAL, SOCIAL, ECONOMIC, ETHICAL AND LEGAL SCIENCES. IN LINE WITH THE UNANTICIPATED UNDERPINNING EPIGENETIC MECHANISMS ARE ALSO THE SOCIAL ISSUES (INCLUDING PUBLIC POLICIES) THAT COULD BE PRODUCED BY THE KNOWLEDGE RELATED TO DOHAD THAT OPENS A WIDE FIELD OF INQUIRY. THE INFORMATION UNVEILED BY EPIGENETICS COUPLED WITH INFORMATION ON LIFESTYLE INCLUDING DURING THE DEVELOPMENT PHASE, IS OF UNFORESEEN NATURE, RAISING ISSUES OF DIFFERENT NATURE. THEREFORE IT REQUIRES SPECIFIC ATTENTION AND RESEARCH, AND A SPECIFIC SUPPORT BY A PLURIDISCIPLINARY REFLECTION SINCE THE VERY BEGINNING OF ITS PRODUCTION, TO ANTICIPATE THE QUESTIONS THAT MIGHT BE RAISED IN THE FUTURE. 2016 15 5469 18 RESOLUTION OF INFLAMMATION AS A NOVEL CHEMOPREVENTIVE STRATEGY. ACUTE INFLAMMATION, A PHYSIOLOGIC RESPONSE TO PROTECT CELLS FROM MICROBIAL INFECTION AND OTHER NOXIOUS STIMULI, IS AUTOMATICALLY TERMINATED BY ENDOGENOUS ANTI-INFLAMMATORY AND PRO-RESOLVING MEDIATORS TO RESTORE HOMEOSTATIC CONDITIONS. HOWEVER, IF TIMELY RESOLUTION OF INFLAMMATION IS FAILED, INFLAMMATION PERSISTS AND CAN PROGRESS TO A CHRONIC INFLAMMATION WHICH HAS LONG BEEN THOUGHT AS A PREDISPOSING FACTOR TO CARCINOGENESIS. EXCESSIVE AND PATHOLOGIC INFLAMMATION CAUSES DNA DAMAGE, GENOMIC INSTABILITY, EPIGENETIC DYSREGULATION, AND ALTERATION OF INTRACELLULAR SIGNALING, ALL OF WHICH ARE INVOLVED IN NEOPLASTIC TRANSFORMATION. TO PREVENT CHRONIC INFLAMMATION AND RESULTING INFLAMMATION-PROMOTED CANCER DEVELOPMENT, UNDERSTANDING THE PROCESS THAT RESOLVES INFLAMMATION IS ESSENTIAL. RESOLUTION OF INFLAMMATION IS AN ACTIVE COORDINATED PROCESS REGULATED BY DISTINCT ANTI-INFLAMMATORY AND PRO-RESOLVING ENDOGENOUS LIPID MEDIATORS, SUCH AS RESOLVINS AND LIPOXINS. THE ROLE OF PRO-INFLAMMATORY SIGNALING IN CARCINOGENESIS HAS BECOME MORE AND MORE EVIDENT AND WELL CHARACTERIZED, BUT THE POTENTIAL ROLE OF PRO-RESOLVING MEDIATORS IN CANCER PREVENTION REMAINS STILL ELUSIVE. IN SEARCHING FOR AN EFFICACIOUS WAY TO PREVENT CHRONIC INFLAMMATION-ASSOCIATED CANCER, THE PRO-RESOLVING SIGNAL TRANSDUCTION PATHWAYS AND THEIR REGULATORS SHOULD BE UNRAVELED. 2013 16 4716 25 NON-GENETIC RATS MODELS FOR ATHEROSCLEROSIS RESEARCH: FROM PAST TO PRESENT. ATHEROSCLEROSIS IS AN INFLAMMATORY, PROGRESSIVE, AND CHRONIC ILLNESS THAT INVOLVES SEVERAL MOLECULAR AND EPIGENETIC FACTORS. DESPITE TREATMENT LIMITATIONS, CLINICAL AND THERAPEUTIC APPROACHES HAVE UNDENIABLY CHANGED RADICALLY IN RECENT DECADES THROUGH BETTER KNOWLEDGE OF THE PATHOPHYSIOLOGICAL BASIS OF THE DISEASE, WHICH HAS CONSIDERABLY IMPROVED PATIENTS' SURVIVAL AND QUALITY OF LIFE. SOME OF THESE ADVANCES ARE ATTRIBUTABLE TO BASIC BIOMEDICAL RESEARCH THAT PROVIDES INSIGHTS INTO A BETTER UNDERSTANDING AND IDENTIFICATION OF NEW MOLECULAR AND CELLULAR TARGETS FOR ATHEROSCLEROSIS TREATMENT. ALTHOUGH RODENT MODELS HAVE CONTRIBUTED SUBSTANTIALLY TO A BETTER UNDERSTANDING OF THE DEVELOPMENT OF ATHEROSCLEROSIS, THE ACCURACY OF THESE MODELS REMAINS CONTROVERSIAL. RESEARCH THAT UTILIZES GENETIC RODENT MODELS IS WELL ESTABLISHED, BUT THE USE OF SPECIFIC DIETS THAT ARE ASSOCIATED WITH OTHER RISK FACTORS (E.G., HYPERTENSION, HORMONE DEPRIVATION, AND PHARMACOLOGICAL TOOLS) IS STILL DEBATABLE. THE PRESENT REVIEW PROVIDES AN UPDATE ON NON-GENETIC RAT MODELS OF ATHEROSCLEROSIS AND AN OVERVIEW OF THE MAIN METHODOLOGIES THAT ARE CURRENTLY AVAILABLE. 2019 17 3169 29 GUIDE FOR CURRENT NUTRIGENETIC, NUTRIGENOMIC, AND NUTRIEPIGENETIC APPROACHES FOR PRECISION NUTRITION INVOLVING THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES ASSOCIATED WITH OBESITY. CHRONIC DISEASES, INCLUDING OBESITY, ARE MAJOR CAUSES OF MORBIDITY AND MORTALITY IN MOST COUNTRIES. THE ADVERSE IMPACTS OF OBESITY AND ASSOCIATED COMORBIDITIES ON HEALTH REMAIN A MAJOR CONCERN DUE TO THE LACK OF EFFECTIVE INTERVENTIONS FOR PREVENTION AND MANAGEMENT. PRECISION NUTRITION IS AN EMERGING THERAPEUTIC APPROACH THAT TAKES INTO ACCOUNT AN INDIVIDUAL'S GENETIC AND EPIGENETIC INFORMATION, AS WELL AS AGE, GENDER, OR PARTICULAR PHYSIOPATHOLOGICAL STATUS. ADVANCES IN GENOMIC SCIENCES ARE CONTRIBUTING TO A BETTER UNDERSTANDING OF THE ROLE OF GENETIC VARIANTS AND EPIGENETIC SIGNATURES AS WELL AS GENE EXPRESSION PATTERNS IN THE DEVELOPMENT OF DIVERSE CHRONIC CONDITIONS, AND HOW THEY MAY MODIFY THERAPEUTIC RESPONSES. THIS KNOWLEDGE HAS LED TO THE SEARCH FOR GENETIC AND EPIGENETIC BIOMARKERS TO PREDICT THE RISK OF DEVELOPING CHRONIC DISEASES AND PERSONALIZING THEIR PREVENTION AND TREATMENT. ADDITIONALLY, ORIGINAL NUTRITIONAL INTERVENTIONS BASED ON NUTRIENTS AND BIOACTIVE DIETARY COMPOUNDS THAT CAN MODIFY EPIGENETIC MARKS AND GENE EXPRESSION HAVE BEEN IMPLEMENTED. ALTHOUGH CAUTION MUST BE EXERCISED, THESE SCIENTIFIC INSIGHTS ARE PAVING THE WAY FOR THE DESIGN OF INNOVATIVE STRATEGIES FOR THE CONTROL OF CHRONIC DISEASES ACCOMPANYING OBESITY. THIS DOCUMENT PROVIDES A NUMBER OF EXAMPLES OF THE HUGE POTENTIAL OF UNDERSTANDING NUTRIGENETIC, NUTRIGENOMIC, AND NUTRIEPIGENETIC ROLES IN PRECISION NUTRITION. 2017 18 465 26 ARE TARGETED THERAPIES FOR DIABETIC CARDIOMYOPATHY ON THE HORIZON? DIABETES INCREASES THE RISK OF HEART FAILURE APPROXIMATELY 2.5-FOLD, INDEPENDENT OF CORONARY ARTERY DISEASE AND OTHER COMORBIDITIES. THIS PROCESS, TERMED DIABETIC CARDIOMYOPATHY, IS CHARACTERIZED BY INITIAL IMPAIRMENT OF LEFT VENTRICULAR (LV) RELAXATION FOLLOWED BY LV CONTRACTILE DYSFUNCTION. POST-MORTEM EXAMINATION REVEALS THAT HUMAN DIASTOLIC DYSFUNCTION IS CLOSELY ASSOCIATED WITH LV DAMAGE, INCLUDING CARDIOMYOCYTE HYPERTROPHY, APOPTOSIS AND FIBROSIS, WITH IMPAIRED CORONARY MICROVASCULAR PERFUSION. THE PATHOPHYSIOLOGICAL MECHANISMS UNDERPINNING THE CHARACTERISTIC FEATURES OF DIABETIC CARDIOMYOPATHY REMAIN POORLY UNDERSTOOD, ALTHOUGH MULTIPLE FACTORS INCLUDING ALTERED LIPID METABOLISM, MITOCHONDRIAL DYSFUNCTION, OXIDATIVE STRESS, ENDOPLASMIC RETICULUM (ER) STRESS, INFLAMMATION, AS WELL AS EPIGENETIC CHANGES, ARE IMPLICATED. DESPITE A RECENT RISE IN RESEARCH INTERROGATING THESE MECHANISMS AND AN INCREASED UNDERSTANDING OF THE CLINICAL IMPORTANCE OF DIABETIC CARDIOMYOPATHY, THERE REMAINS A LACK OF SPECIFIC TREATMENT STRATEGIES. HOW THE CHRONIC METABOLIC DISTURBANCES OBSERVED IN DIABETES LEAD TO STRUCTURAL AND FUNCTIONAL CHANGES REMAINS A PERTINENT QUESTION, AND IT IS HOPED THAT RECENT ADVANCES, PARTICULARLY IN THE AREA OF EPIGENETICS, AMONG OTHERS, MAY PROVIDE SOME ANSWERS. THIS REVIEW HENCE EXPLORES THE TEMPORAL ONSET OF THE PATHOLOGICAL FEATURES OF DIABETIC CARDIOMYOPATHY, AND THEIR RELATIVE CONTRIBUTION TO THE RESULTANT DISEASE PHENOTYPE, AS WELL AS BOTH CURRENT AND POTENTIAL THERAPEUTIC OPTIONS. THE EMERGENCE OF GLUCOSE-OPTIMIZING AGENTS, NAMELY GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS AND SODIUM/GLUCOSE CO-TRANSPORTER (SGLT)2 INHIBITORS THAT CONFER BENEFITS ON CARDIOVASCULAR OUTCOMES, TOGETHER WITH NOVEL EXPERIMENTAL APPROACHES, HIGHLIGHT A NEW AND EXCITING ERA IN DIABETES RESEARCH, WHICH IS LIKELY TO RESULT IN MAJOR CLINICAL IMPACT. 2017 19 734 27 CANCER HEALTHCARE DISPARITIES AMONG AFRICAN AMERICANS IN THE UNITED STATES. A NEED EXISTS TO EXAMINE RACIAL DISPARITIES IN THE HEALTHCARE ARENA AND THE IMPACT ON PATIENTS WITH CANCER. DESPITE ONGOING EFFORTS TO INCREASE EQUITY IN PRIMARY HEALTHCARE ACCESS, RACIAL AND SOCIOECONOMIC DISPARITIES PERSIST, THUS CONTRIBUTING TO DISPROPORTIONATE TREATMENT OUTCOMES AND SURVIVORSHIP AMONG MINORITY AND LOW-INCOME PATIENTS. SUCH DISPARITIES HAVE BEEN REVEALED IN TREATMENT COHORTS OF PATIENTS WITH MULTIPLE FORMS OF CANCER, INCLUDING BREAST, CERVICAL, OVARIAN, ENDOMETRIAL, PROSTATE, LUNG, COLORECTAL, GASTROINTESTINAL, AND HEPATOCELLULAR, AND HAVE BEEN ATTRIBUTED TO A RANGE OF CO-OCCURRING BEHAVIORAL, SOCIAL DETERMINANTS OF HEALTH, UNDERLYING GENETIC FACTORS, AS WELL AS ACCESS TO EDUCATIONAL OPPORTUNITIES THAT LIMIT THE QUALITY OF INFORMED HEALTHCARE. THESE VARIOUS INTERRELATED FACTORS WIDEN CANCER HEALTHCARE DISPARITIES SYNERGISTICALLY THROUGHOUT UNDERSERVED COMMUNITIES, AND THEIR INFLUENCE HAS BEEN AMPLIFIED BY THE CORONAVIRUS DISEASE 2019 (COVID-19) PANDEMIC. FUNDAMENTALLY, A LACK OF BASIC AND CLINICAL RESEARCH EXISTS THAT FAILS TO ADEQUATELY REFLECT DIVERSITY AND MINORITY INVOLVEMENT IN DRUG DEVELOPMENT. ALTHOUGH OVERCOMING THE OBSTACLES RESPONSIBLE FOR CHRONIC TREATMENT DISPARITIES IS A FORMIDABLE TASK, PROMISING MEANS OF ACHIEVING MORE UNIFORM QUALITY HEALTHCARE ARE BECOMING MORE CLEARLY ELUCIDATED. TO REDUCE DISEASE PROGRESSION, INCREASE OVERALL SURVIVAL, AND IMPROVE THE HEALTH OF VULNERABLE POPULATIONS, IT IS NECESSARY TO IDENTIFY AND FULLY DISCLOSE ENVIRONMENTAL, BIOLOGICAL, AND ANCESTRAL FACTORS THAT IMPACT THE RISK FOR CANCER; HEAL HISTORICAL FRACTURES WITHIN COMMUNITIES; AND INCREASE PARTICIPATION OF RACIAL AND ETHNIC MINORITIES IN SCREENING EFFORTS AND RESEARCH STUDIES. THIS REQUIRES DEVELOPING A SYSTEM OF JUSTICE AND TRUST BASED ON SPECIFIC, SOLUTION-ORIENTED GRASSROOTS COMMUNITY EFFORTS WORKING IN TANDEM WITH MEDICAL AND PHARMACEUTICAL LEADERS. BY FULLY EXPLORING AND PINPOINTING THE UNDERLYING CAUSES OF HEALTHCARE DISPARITIES, IT SHOULD BE POSSIBLE TO DEFINE STRATEGIES AND INTERVENTIONS MOST LIKELY TO TRANSFORM CANCER CARE. THE ULTIMATE GOAL IS UNDERSTANDING INDIVIDUAL, CULTURAL, AND BIOLOGICAL VULNERABILITIES, INCLUDING ENVIRONMENTAL AND EPIGENETIC LIABILITIES, TO OPTIMIZE CANCER PREVENTION, DIAGNOSIS, AND TREATMENT. 2022 20 3668 28 INFLAMMAGEING AND METAFLAMMATION: THE YIN AND YANG OF TYPE 2 DIABETES. TYPE 2 DIABETES MELLITUS (T2DM) IS CHARACTERISED BY CHRONIC LOW-GRADE INFLAMMATION, RECENTLY REFERRED TO AS 'METAFLAMMATION', A RELEVANT FACTOR CONTRIBUTING TO THE DEVELOPMENT OF BOTH DIABETES AND ITS COMPLICATIONS. NONETHELESS, 'CANONICAL' ANTI-INFLAMMATORY DRUGS DO NOT YIELD SATISFACTORY RESULTS IN TERMS OF PREVENTION OF DIABETES PROGRESSION AND OF CARDIOVASCULAR EVENTS, SUGGESTING THAT THE CAUSAL MECHANISMS FOSTERING METAFLAMMATION DESERVE FURTHER RESEARCH TO IDENTIFY NEW DRUGGABLE TARGETS. METAFLAMMATION RESEMBLES AGEING-INDUCED LOW-GRADE INFLAMMATION, PREVIOUSLY REFERRED TO AS INFLAMMAGEING, IN TERMS OF CLINICAL PRESENTATION AND THE MOLECULAR PROFILE, POINTING TO A COMMON AETIOLOGY FOR BOTH CONDITIONS. ALONG WITH THE MECHANISMS PROPOSED TO FUEL INFLAMMAGEING, HERE WE DISSECT A PLETHORA OF PATHOLOGICAL CASCADES TRIGGERED BY GLUCO- AND LIPOTOXICITY, CONVERGING ON CANDIDATE PHENOMENA POSSIBLY EXPLAINING THE ENDURING PRO-INFLAMMATORY PROGRAM OBSERVED IN DIABETIC TISSUES, I.E. PERSISTENT IMMUNE-SYSTEM STIMULATION, ACCUMULATION OF SENESCENT CELLS, EPIGENETIC REARRANGEMENTS, AND ALTERATIONS IN MICROBIOTA COMPOSITION. WE DISCUSS THE POSSIBILITY OF HARNESSING THESE RECENT DISCOVERIES IN FUTURE THERAPIES FOR T2DM. MOREOVER, WE REVIEW RECENT EVIDENCE REGARDING THE ABILITY OF DIETS AND PHYSICAL EXERCISE TO MODULATE SELECTED INFLAMMATORY PATHWAYS RELEVANT FOR THE DIABETIC PATHOLOGY. FINALLY, WE EXAMINE THE LATEST FINDINGS SHOWING PUTATIVE ANTI-INFLAMMATORY MECHANISMS OF ANTI-HYPERGLYCAEMIC AGENTS WITH PROVEN EFFICACY AGAINST T2DM-INDUCED CARDIOVASCULAR COMPLICATIONS, IN ORDER TO GAIN INSIGHTS INTO QUICKLY TRANSLATABLE THERAPEUTIC APPROACHES. 2018